Table 2:
Beta-coefficients for all 10-year outcomes
| ASCVD | MI | Stroke | HF | All-Cause Mortality | Fatal ASCVD | Fatal MI | Fatal Stroke | |
|---|---|---|---|---|---|---|---|---|
| (1,696 events) | (927 events) | (865 events) | (885 events) | (2,843 events) | (446 events) | (301 events) | (145 events) | |
| Female | −0.49 | −0.475 | 0.46 | −0.242 | −0.475 | |||
| White | −0.33 | −1.223 | −0.93 | −0.22 | −1.22 | |||
| Black | 0.36 | 1.374 | 1.37 | |||||
| Current smoker | 0.70 | 0.742 | 0.51 | 0.632 | −0.0037 | −0.00525 | 0.0024 | |
| BMI | 0.0024 | 0.004 | 0.0393 | −0.00048 | 0.00558 | 0.0072 | 0.001 | |
| LDL | 0.0058 | 0.0083 | 0.001 | −0.223 | 0.097 | |||
| Cholesterol tx | −0.00617 | 0.097 | 0.778 | 0.818 | 0.862 | 0.63 | ||
| Diabetes | 0.689 | 0.6910 | 0.631 | 0.708 | 0.0055 | 0.0176 | 0.0142 | 0.012 |
| SBP | 0.0117 | 0.0095 | 0.012 | 0.0109 | 0.409 | 0.715 | 0.521 | 1.82 |
| BP tx | 1.384 | 0.87 | 1.819 | 0.386 | 0.734 | 0.526 | 0.224 | 0.34 |
| Atrial fibrillation | 0.35 | 0.291 | 0.344 | 1.287 | −0.0059 | −0.0086 | −0.0094 | −0.001 |
| eGFR | −0.0027 | −0.0046 | −0.0012 | −0.0095 | 0.0185 | 0.00402 | 0.0102 | −0.0002 |
| Age X Age | 0.00038 | 0.0004 | 0.00051 | 0.0015 | ||||
| Black X Age | −0.0168 | −0.0083 | −0.027 | 0.0006 | 0.000488 | 0.000032 | 0.0004 | |
| Hispanic X Age | 0.00023 | 0.013 | 0.0183 | 0.0129 | ||||
| Age | 0.0247 | −0.0033 | −0.027 | |||||
| Black X SBP | 0.00244 | 0.00073 | 0.0027 | −0.0000307 | 0.00312 | 0.0487 | ||
| Hispanic X SBP | −0.00172 | −0.0063 | −0.0005 | −0.00107 | ||||
| LDL X Off Cholesterol Treatment | 0.00010 | 0.0015 | 0.00474 | 0.00117 | 0.00228 | 0.0027 | ||
| SBP X On Blood Pressure Treatment | 0.00663 | 0.0035 | 0.0092 | −0.000229 | 0.0015 | |||
| Male X Age | 0.0116 | −0.00024 | 0.00475 | 0.00173 | 0.00133 | 0.0092 | ||
| LDL X On Cholesterol Treatment | 0.000558 | −0.00106 | 0.000576 | 0.00175 | ||||
| Female X Age | 0.00914 | 1.37 | ||||||
| Male X SBP | 0.00206 | 0.009 | ||||||
| White X Age | 0.0129 | 0.002 | ||||||
| White X SBP | 0.000709 | 0.000 | ||||||
| CHS | 0.76 | 0.71 | 0.91 | 3.151 | −0.136 | −0.593 | −0.88 | 0.91 |
| FHS | 0.80 | 0.79 | 0.69 | 1.997 | 0.351 | 0.901 | 0.866 | 0.69 |
| MESA | −0.0438 | −0.275 | 0.17 | 2.114 | −0.413 | −0.291 | −0.232 | 0.17 |
| NOMAS | 0.244 | −0.306 | 0.64 | 2.75 | −0.0647 | −0.762 | −1.066 | 0.64 |
| Constant | −7.469 | −8.39 | −8.96 | −10.27 | −6.197 | −9.037 | −10.61 | −8.96 |
| Observations | 24505 | 24505 | 24505 | 24505 | 24505 | 24505 | 24505 | 24505 |
Legend: Non-predictive variables are naturally removed in this modeling technique.
Abbreviations: ASCVD atherosclerotic cardiovascular disease, BMI body mass index, BP blood pressure, BP tx blood pressure treatment, CHS Cardiovascular Health Study, eGFR estimated glomerular filtration rate, Framingham Offspring Study (FOS), LDL low density lipoprotein, MESA Multi-Ethnic Study of Atherosclerosis, MI myocardial infarction, NOMAS Northern Manhattan Study, SBP systolic blood pressure